Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients

MLA

Thomas G. Berger, et al. “Differences in Phenotype and Function between Spontaneously Occurring Melan-A-, Tyrosinase- and Influenza Matrix Peptide-Specific CTL in HLA-A*0201 Melanoma Patients.” International Journal of Cancer, vol. 115, no. 3, Feb. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46a57e901ef2055ce51ae4a2ce1b0bb7&authtype=sso&custid=ns315887.

APA

Thomas G. Berger, Gerold Schuler, Vincenzo Cerundolo, Anett Hamann, Beatrice Schuler-Thurner, Erwin S. Schultz, P. Rod Dunbar, Alexander Steinkasserer, & Christian Maczek. (2005). Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients. International Journal of Cancer, 115(3).

Chicago

Thomas G. Berger, Gerold Schuler, Vincenzo Cerundolo, Anett Hamann, Beatrice Schuler-Thurner, Erwin S. Schultz, P. Rod Dunbar, Alexander Steinkasserer, and Christian Maczek. 2005. “Differences in Phenotype and Function between Spontaneously Occurring Melan-A-, Tyrosinase- and Influenza Matrix Peptide-Specific CTL in HLA-A*0201 Melanoma Patients.” International Journal of Cancer 115 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46a57e901ef2055ce51ae4a2ce1b0bb7&authtype=sso&custid=ns315887.